Skuladottir H, Olsen JH. Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark. J Clin Oncol 2003;21:3035–3040.
Bianchi M, Becker A, Hansen J, . Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time. BJU Int 2013;111:E283–289.
Karakiewicz PI, Suardi N, Capitanio U, . Conditional survival predictions after nephrectomy for renal cell carcinoma. J Urol 2009;182:2607–2612.
Hieke S, Kleber M, König C, . Conditional survival: a useful concept to provide information on how prognosis evolves over time. Clin Cancer Res 2015;21:1530–1536.
Stephenson AJ, Scardino PT, Eastham JA, . Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005;23:7005–7012.
Sun M, Abdollah F, Bianchi M, . Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy. Eur J Cancer 2012;48:1503–1511.
Ploussard G, Shariat SF, Dragomir A, . Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. Eur Urol 2014;66:361–370.
Groth SS, Rueth NM, Hodges JS, . Conditional cancer-specific versus cardiovascular-specific survival after lobectomy for stage I non-small cell lung cancer. Ann Thorac Surg 2010;90:375–382.
Harshman LC, Xie W, Bjarnason GA, . Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study. Lancet Oncol 2012;13:927–935.
Abdollah F, Suardi N, Capitanio U, . The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis. Urol Oncol 2014;32:43.e9–43.e16.
Kang M, Park JY, Jeong CW, . Changeable conditional survival rates and associated prognosticators in patients with metastatic renal cell carcinoma receiving first line targeted therapy. J Urol 2018;200:989–995.
Turner RM II, Morgan TM, Jacobs BL. Epidemiology of the small renal mass and the treatment disconnect phenomenon. Urol Clin North Am 2017;44:147–154.
Ljungberg B, Albiges L, Bensalah K, . European Association of Urology Guidelines, 2018 edition. Presented at the 32nd Annual EAU Congress; March 16–20, 2018; Copenhagen, Denmark.
Brookman-May S, May M, Shariat SF, . Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). Eur Urol 2013;64:472–477.
- Search Google Scholar
- Export Citation
)| false . , Brookman-May S , May M , Shariat SF Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project). 2013; 64: 472– 477.